{"version":"1.0","type":"link","title":"A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma.","author_name":"Xu N 외","author_url":"https://prs-insight.online/author/Xu%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168422","thumbnail_width":1200,"thumbnail_height":630}